Literature DB >> 16900370

[Renal cell carcinoma].

A Haferkamp1, D Rohde, S C Müller, H Rübben, M Hohenfellner.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16900370     DOI： 10.1007/s00120-006-1136-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  132 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.

Authors:  J C Cheville; M L Blute; H Zincke; C M Lohse; A L Weaver
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

3.  Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

Authors:  N B Itano; M L Blute; B Spotts; H Zincke
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

4.  Reassessing the current TNM lymph node staging for renal cell carcinoma.

Authors:  Carlo Terrone; C Cracco; F Porpiglia; E Bollito; C Scoffone; M Poggio; A Berruti; F Ragni; M Cossu; R M Scarpa; S Rocca Rossetti
Journal:  Eur Urol       Date:  2005-12-20       Impact factor: 20.096

Review 5.  Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis.

Authors:  J N Eble; S M Bonsib
Journal:  Semin Diagn Pathol       Date:  1998-02       Impact factor: 3.464

6.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

7.  Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients.

Authors:  P V Targonski; W Frank; D Stuhldreher; P D Guinan
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

8.  Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Authors:  Joseph I Clark; Michael B Atkins; Walter J Urba; Steven Creech; Robert A Figlin; Janice P Dutcher; Larry Flaherty; Jeffrey A Sosman; Theodore F Logan; Richard White; Geoffrey R Weiss; Bruce G Redman; Christopher P G Tretter; David McDermott; John W Smith; Michael S Gordon; Kim A Margolin
Journal:  J Clin Oncol       Date:  2003-06-16       Impact factor: 44.544

9.  Laparoscopic radical nephrectomy: techniques, results and oncological outcome in 125 consecutive cases.

Authors:  Andreas H Wille; Jan Roigas; Serdar Deger; Maximilian Tüllmann; Ingolf Türk; Stefan A Loening
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

10.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394
View more
  1 in total

1.  [Gender-specific characteristics and survival of renal cell carcinoma].

Authors:  A J Schrader; S Sevinc; P J Olbert; A Hegele; Z Varga; R Hofmann
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.